Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - EPIRUS Biopharmaceuticals, Inc. | Financial_Report.xls |
| EX-31.1 - EX-31.1 - EPIRUS Biopharmaceuticals, Inc. | a14-21803_1ex31d1.htm |
| EX-10.1 - EX-10.1 - EPIRUS Biopharmaceuticals, Inc. | a14-21803_1ex10d1.htm |
| EX-10.4 - EX-10.4 - EPIRUS Biopharmaceuticals, Inc. | a14-21803_1ex10d4.htm |
| EX-10.6 - EX-10.6 - EPIRUS Biopharmaceuticals, Inc. | a14-21803_1ex10d6.htm |
| EX-99.1 - EX-99.1 - EPIRUS Biopharmaceuticals, Inc. | a14-21803_1ex99d1.htm |
| EX-31.2 - EX-31.2 - EPIRUS Biopharmaceuticals, Inc. | a14-21803_1ex31d2.htm |
| 10-Q - 10-Q - EPIRUS Biopharmaceuticals, Inc. | a14-21803_110q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer and principal financial officer of EPIRUS Biopharmaceuticals, Inc. (the “Company”), do hereby certify that to their knowledge:
1) the Company’s Form 10-Q for the fiscal quarter ended September 30, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2) the information contained in the Company’s Form 10-Q for the fiscal quarter ended September 30, 2014 fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Amit Munshi |
|
|
Amit Munshi |
|
|
President and Chief Executive Officer |
|
|
(principal executive officer) |
|
|
|
|
|
/s/ Thomas Shea |
|
|
Thomas Shea |
|
|
Chief Financial Officer and Treasurer |
|
|
(principal financial officer) |
|
|
|
|
Dated: November 10, 2014 |
|